SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-221838
Filing Date
2021-07-22
Accepted
2021-07-22 16:06:24
Documents
14
Period of Report
2021-07-22
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d85319d8k.htm   iXBRL 8-K 24835
2 EX-99.1 d85319dex991.htm EX-99.1 9003
6 GRAPHIC g85319g24j49.jpg GRAPHIC 3212
  Complete submission text file 0001193125-21-221838.txt   164434

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cbio-20210722.xsd EX-101.SCH 2925
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbio-20210722_lab.xml EX-101.LAB 18139
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbio-20210722_pre.xml EX-101.PRE 11430
7 EXTRACTED XBRL INSTANCE DOCUMENT d85319d8k_htm.xml XML 3341
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Filer) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51173 | Film No.: 211107675
SIC: 2834 Pharmaceutical Preparations